New Tricks for Old Targets: Anti-Ctla-4 Antibodies Re-Envisioned for Cancer Immunotherapy

Oncotarget - United States
doi 10.18632/oncotarget.25800
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Old Dog Begging for New Tricks

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2016English

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

New Tricks for an Old Antibiotic♦

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

New Tricks for an Old-Favorite Model

Genome Biology
2009English

Intestinal Microbiota Predict Response and Toxicities During Anti-Pd-1/Anti-Ctla-4 Immunotherapy

Pathology
Forensic MedicinePathology
2020English

New Drugs for Old Targets

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Treatment of COVID-19: Old Tricks for New Challenges

Critical Care
Critical CareIntensive Care Medicine
2020English

CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients

JCI insight
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy